sj-docx-3-mso-10.1177_20552173241238632 - Supplemental material for Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program

Supplemental material, sj-docx-3-mso-10.1177_20552173241238632 for Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program by Marco Salvetti, Sibyl Wray, Gereon Nelles, Nicholas Belviso, Achint Kumar, Thijs Koster, Wanda Castro-Borrero, Megan Vignos and in Multiple Sclerosis Journal – Experimental, Translational and Clinical